Miles, D W <br/><br/>
Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil.  [electronic resource] 

 -  International journal of cancer  Aug 1999 
 - 354-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0215(19990820)84:4<354::aid-ijc4>3.0.co;2-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--mortality<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Lymph Node Excision<br/>Lymphatic Metastasis<br/>Mastectomy<br/>Menopause<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Predictive Value of Tests<br/>Receptor, ErbB-2--analysis<br/>Receptors, Estrogen--analysis<br/>Regression Analysis<br/>Survival Rate<br/>Time Factors